- Home
- ACIC vs PAHC Comparison
ACIC vs PAHC Comparison
Compare ACIC & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIC
- PAHC
- Stock Information
- Founded
- ACIC 1999
- PAHC 1946
- Country
- ACIC United States
- PAHC United States
- Employees
- ACIC N/A
- PAHC N/A
- Industry
- ACIC Property-Casualty Insurers
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- ACIC Finance
- PAHC Health Care
- Exchange
- ACIC Nasdaq
- PAHC Nasdaq
- Market Cap
- ACIC 514.2M
- PAHC 682.5M
- IPO Year
- ACIC N/A
- PAHC 2014
- Fundamental
- Price
- ACIC $11.02
- PAHC $21.04
- Analyst Decision
- ACIC Buy
- PAHC Sell
- Analyst Count
- ACIC 1
- PAHC 4
- Target Price
- ACIC $15.00
- PAHC $16.50
- AVG Volume (30 Days)
- ACIC 206.3K
- PAHC 201.1K
- Earning Date
- ACIC 11-11-2024
- PAHC 11-06-2024
- Dividend Yield
- ACIC N/A
- PAHC 2.29%
- EPS Growth
- ACIC N/A
- PAHC N/A
- EPS
- ACIC 1.43
- PAHC 0.06
- Revenue
- ACIC $261,180,000.00
- PAHC $1,017,679,000.00
- Revenue This Year
- ACIC N/A
- PAHC $15.85
- Revenue Next Year
- ACIC $13.95
- PAHC $11.79
- P/E Ratio
- ACIC $7.73
- PAHC $351.73
- Revenue Growth
- ACIC N/A
- PAHC 4.07
- 52 Week Low
- ACIC $6.82
- PAHC $9.40
- 52 Week High
- ACIC $14.38
- PAHC $22.84
- Technical
- Relative Strength Index (RSI)
- ACIC 47.53
- PAHC 51.90
- Support Level
- ACIC $10.79
- PAHC $21.80
- Resistance Level
- ACIC $11.74
- PAHC $22.84
- Average True Range (ATR)
- ACIC 0.37
- PAHC 0.61
- MACD
- ACIC -0.01
- PAHC -0.15
- Stochastic Oscillator
- ACIC 25.77
- PAHC 18.29
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary. The company has two segments namely: Commercial Lines Business and Personal Lines Business. It derives maximum revenue from Commercial Lines Business Segment.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.